This transfection efficiency does not seem to depend on the BCR-ABL fusion protein as a crucial point, since no other tested CML or AML cell line with this fusion protein could be transfected. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.